Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TetMYB |
Trade Name | |
Synonyms | MYB vaccine |
Drug Descriptions |
TetMYB is a DNA vaccine comprised of a modified full-length MYB coding region linked to tetanus peptides, which results in enhanced immune response to MYB expressing tumor cells (Gastroenterology, Volume 154, Issue 6, Supplement 1, May 2018, Pages S-1269, PMID: 25671128, PMID: 31650066). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C153094 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TetMYB | TetMYB | 1 | 0 |
TetMYB + Tislelizumab | TetMYB Tislelizumab | 0 | 1 |